Research

Hormonal

Combining dulaglutide (1.5 mg weekly) with a low-energy diet (825 kcal/day) significantly improves weight loss and glycaemic control in individuals with type 2 diabetes and obesity compared to baseline, while maintaining high adherence and tolerability.

If you have type 2 diabetes and obesity, combining a once-weekly GLP-1 medication (dulaglutide) with a strict low-calorie diet (around 825 calories/day) can lead to significant weight loss (approx. 9.5 kg) and better blood sugar control. This approach helps manage hunger, making it easier to stick to the diet. Always consult your doctor before stopping current diabetes or blood pressure medications.

ModerateSupportsMEDIUM confidence
Participants achieved an average weight loss of 9.5 kg and a mean reduction in haemoglobin A1c of 15.8 mmol/mol... Eighty-nine per cent of participants completed the 12-week dietary intervention.
James A. D. Shand et al. · BMJ Nutrition Prevention & Health · 2023

Why this rating

Single-arm pilot study with small sample size (n=19) and no control group limits causal inference regarding the specific contribution of dulaglutide versus the diet alone.

Source

Pilot study to test the safety, tolerability and feasibility of dulaglutide during a low-energy diet for weight loss and improved glycaemic control

James A. D. Shand et al. · BMJ Nutrition Prevention & Health · 2023

DOI 10.1136/bmjnph-2023-000733

clinical_trial · n=19Cited 7×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →